As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

SHOPPING: If you're ready to take control of your weight loss goals, turn to Get Thin MD for prescription GLP-1 medications ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the ...

Research suggests that there may be safer ways of supressing your appetite without resorting to weight-loss drugs.

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...